News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

Roche (RHHBY) Agenus (AGEN Illumina (ILMN) Pluristem (PSTI) Mirati Therapeutics (MRTX) Seattle Genetics (SGEN) ABBVIE (ABBV) Merck (MRK) AERIE PHARMACEUTICALS GUARDIAN HEALTH NEKTAR (NKTR)) Genentech Theravance Bio Pharma (TBPH) Intermune (ITMN) JUNO (JUNO) Roche (ROCHE) TOKAI (TKAOI) Human Longevity (HLI) Human Genome Sciences (HGSI) ACADIA (ACAD) KITE (KITE) Galena (GALE) Biogen Idec (BIIB) Sequenom (SQNM) Benlysta (belimumab) AGOS (ARGS) Intercept (ICPT) Abbott Laboratories (ABT) IDERA (IDRA) Zerenex Elan (ELN) Vitae Pharmaceuticals (VTAE) Biocryst (BCRX) galapagos (GLPG) SERES THERAPEUTICS (MCRB) Anadys (ANDS) Editas (EDIT) Ariad (ARIA) Sanofi (SNA) Incyte (INCY) Alder Biopharmaceuticals (ALDR) Ridaforolimus Sarepta (SRPT) Alnylam (ALNY) VANDA (VNDA) Onyx (ONXX) ISIS (ISIS) Agenus (AGEN) Revlimid (lenolidamide) Dynavax (DVAX) ImmunoGen (IMGN) Sanofi (SNY) Rapamune Ionis (IONS) Prolor Biotech (PBTH) Herceptin Anacor (ANAC) ZALTRAP™ C4 Therapeutics OSI (OSIP) Micromet (MITI) HALOZYME (HALO) BIOMARIN (BMRN) Inovio (INO) SUNESIS PHARMACEUTICALS (SNSS) Intrexon (XON) Telaprevir Sangamo (SGMO) ARGOS (ARGS) Exelixis (EXEL) RenenxBio (RGNX) Vertex (VRTX) Trastuzumab-DM1 CompuGen (CGEN) KERYX (KERX) Theravance (THRX) Cytokinetics (CYTK) Aimmune Therapeutics (AIMT) GlaxoSmithKline (GSK) Regeneron (REGN) SYNTA (SNTA) ADVENTRIX (ANX) Amgen (AMGN) Spike Therapeutics (ONCE) Ziofpharm (ZIOP) Dendreon (DNDN) PTC Therapeutics (PTCT) Xoma (XOMA) ARCA (ABIO) Global Cell Therapeutics (GBT) Prosensa (RNA) Gilead (GILD) Auspex (ASPX) Velcade (bortezomib) Sanofi-Aventis (SAN) Endometrial Cancer Valeant Pharmaceuticals International (VRX) Bristol-Myers Squibb (BMY) Idenix (IDIX) Array Pharmaceuticals (ARRY) REGULUS (RGLS) INNOVIVA (INVA) Tysabri NANTKWEST (NK) Jazz Pharmaceuticals (JAZZ) Multiple Myeloma